NetJets Business Jet Crashes On Texas Highway

"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand Shares of Eli Lilly & Co. are rising in premarket trading after the pharmaceutical giant raised its full-year revenue forecast following a 48% jump in second-quarter sales, fueled by accelerating demand for the diabetes drug Mounjaro and the obesity treatment Zepbound. Lilly's second-quarter results topped Wall Street expectations: Adjusted earnings rose to $8.38 a share from $6.31 a year earlier. Revenue surged 48% to $22.97 billion, beating the $20.59 billion Bloomberg Consensus estimate. Mounjaro generated $9.94 billion in sales, exceeding...

Despite German State Stimulus: Machinery Industry Braces For A Catastrophic Year Submitted by Thomas Kolbe Friedrich Merz does not make it easy to interpret current economic data correctly. The debt king from Brilon is not only distorting the statistics with his “special (debt) assets”: More than 320 billion euros in direct and indirect state subsidies are flowing, according to Freiburg economist Lars Feld, through subsidy channels that are penetrating ever deeper into the German economy. Artificial economies are emerging there, economic homunculi that will remain permanently dependent on the taxpayer. What Is...

Global Gas Crunch Makes Europe's Remaining Coal Plants Profitable By Michael Kern of OilPrice.com The global LNG supply crunch has made Europe’s last-standing coal-fired power plants profitable this year as gas supply costs soar while the need for conventional generation to stabilize grids remains. In Germany and Poland, which host most of the remaining operational or back-up-ready coal power capacity in Europe, coal-fired generation is profitable again as winter approaches, LNG supply is barely moving out of the Strait of Hormuz, and gas prices are at their highest level since the 2022-2023...